BPG is committed to discovery and dissemination of knowledge
Prospective Study
Copyright: ©Author(s) 2026.
World J Virol. Mar 25, 2026; 15(1): 117079
Published online Mar 25, 2026. doi: 10.5501/wjv.v15.i1.117079
Table 1 Serological profile of patients (n = 320), n (%)
Serological category
Criteria
n (%)
Recent dengue infectionNS1+ and/or IgM+90 (28.1)
Probable secondary infectionIgM+ IgG+32 (10.0)
Past exposureIgG+ IgM-112 (35.0)
NegativeNS1- IgM-86 (26.9)
Table 2 Clinical and laboratory features by serostatus, median (25th-75th percentiles)
Parameter
Recent dengue (n = 90)
Non-dengue (n = 230)
P value
Median age (years)30 (20-42)33 (24-45)0.18
Male sex (%)55.657.00.82
Headache (%)68.042.0< 0.001
Rash (%)26.08.00.002
Bleeding signs (%)8.02.00.04
Median platelet count (/mm³)78000 (55000-110000)210000 (160000-240000)< 0.001